Midodrine in treatment of post coronary revascularization vasoplagia; pilot, open label, assessor blinded randomized clinical trial
Event:
ESC Congress 2022
Topic:
Pharmacotherapy
Session:
Treatment of acute heart failure - Pharmacological & non-pharmacological